Kelsey Goodwin
Stock Analyst at Piper Sandler
(4.91)
# 225
Out of 4,690 analysts
93
Total ratings
67.4%
Success rate
59.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelsey Goodwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LONA LeonaBio | Maintained: Buy | $20 | $7.94 | +151.89% | 3 | Aug 27, 2026 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | $40 | $10.27 | +289.48% | 5 | Aug 20, 2026 | |
| ERAS Erasca | Maintained: Buy | $18 → $22 | $18.03 | +22.02% | 6 | Aug 12, 2026 | |
| RLMD Relmada Therapeutics | Maintained: Buy | $12 | $4.33 | +177.14% | 3 | Aug 7, 2026 | |
| JANX Janux Therapeutics | Maintained: Buy | $26 | $18.03 | +44.20% | 8 | Aug 7, 2026 | |
| CGON CG Oncology | Reiterated: Buy | $82 → $85 | $74.34 | +14.34% | 9 | Aug 7, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $8 | $2.23 | +258.74% | 5 | Aug 6, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $172 → $210 | $207.88 | +1.02% | 9 | Aug 6, 2026 | |
| OBX Obsidian Therapeutics | Initiated Coverage: Buy | $42 | $16.30 | +157.67% | 1 | Aug 4, 2026 | |
| ORIC ORIC Pharmaceuticals | Rated: Buy | $22 | $13.24 | +66.16% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $13.73 | +16.53% | 5 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $3.83 | +526.63% | 7 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $24 | $23.34 | +2.83% | 4 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $43.62 | -8.30% | 8 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.83 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $23.43 | +53.65% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.03 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.66 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.01 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.13 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $19.88 | n/a | 1 | Oct 31, 2022 |
LeonaBio
Aug 27, 2026
Maintained: Buy
Price Target: $20
Current: $7.94
Upside: +151.89%
Olema Pharmaceuticals
Aug 20, 2026
Maintained: Buy
Price Target: $40
Current: $10.27
Upside: +289.48%
Erasca
Aug 12, 2026
Maintained: Buy
Price Target: $18 → $22
Current: $18.03
Upside: +22.02%
Relmada Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $12
Current: $4.33
Upside: +177.14%
Janux Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $26
Current: $18.03
Upside: +44.20%
CG Oncology
Aug 7, 2026
Reiterated: Buy
Price Target: $82 → $85
Current: $74.34
Upside: +14.34%
Black Diamond Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $8
Current: $2.23
Upside: +258.74%
Revolution Medicines
Aug 6, 2026
Maintained: Buy
Price Target: $172 → $210
Current: $207.88
Upside: +1.02%
Obsidian Therapeutics
Aug 4, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $16.30
Upside: +157.67%
ORIC Pharmaceuticals
Aug 4, 2026
Rated: Buy
Price Target: $22
Current: $13.24
Upside: +66.16%
Jul 24, 2026
Maintained: Hold
Price Target: $16
Current: $13.73
Upside: +16.53%
May 20, 2026
Maintained: Buy
Price Target: $24
Current: $3.83
Upside: +526.63%
May 15, 2026
Downgraded: Hold
Price Target: $14 → $24
Current: $23.34
Upside: +2.83%
Apr 20, 2026
Maintained: Buy
Price Target: $40
Current: $43.62
Upside: -8.30%
Mar 26, 2026
Maintained: Buy
Price Target: n/a
Current: $1.83
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: $36
Current: $23.43
Upside: +53.65%
May 15, 2025
Reiterated: Buy
Price Target: $5
Current: $2.03
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $8
Current: $2.66
Upside: n/a
Apr 1, 2025
Maintained: Hold
Price Target: n/a
Current: $8.01
Upside: n/a
Jul 30, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.13
Upside: n/a
Oct 31, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $19.88
Upside: n/a